CSF1R and neoplasm: Preclinical studies have shown that targeting CSF-1/CSF-1R signaling depletes tumor-associated macrophages by inducing apoptotic death [75], inhibits their recruitment from circulating monocytes [76], and induces M2–M1 polarization [34].